Literature DB >> 17597793

The woodchuck hepatitis virus post-transcriptional regulatory element reduces readthrough transcription from retroviral vectors.

T Higashimoto1, F Urbinati, A Perumbeti, G Jiang, A Zarzuela, L-J Chang, D B Kohn, P Malik.   

Abstract

The woodchuck hepatitis virus post-transcriptional regulatory element (WPRE) increases transgene expression from a variety of viral vectors, although the precise mechanism is not known. WPRE is most effective when placed downstream of the transgene, proximal to the polyadenylation signal. We hypothesized that WPRE likely reduces viral mRNA readthrough transcription by improving transcript termination, which in turn would increase viral titers and expression. Using a Cre-lox-mediated plasmid-based assay, we found significant readthrough transcription from gamma-retroviral vector (RV) long terminal repeat (wt RV-LTR) and RV LTR with a self-inactivating deletion (SIN RV-LTR). WPRE, when placed upstream of the RV LTRs, significantly reduced readthrough transcription. Readthrough, present at much lower levels with the SIN HIV-1 LV-LTR, was also reduced with WPRE. When placed in RV vectors, WPRE increased total RV genomic mRNA; and increased viral titers from transiently transfected 293T cells and stable PG13 producer cells by 7- to 15-fold. The mechanism of increased titers and expression was not due to increased nuclear mRNA export, increased rate of viral transcription or a significant increase in viral mRNA half-life. Our results showed that WPRE improved vector genomic transcript termination to increase titers and expression from RVs.

Entities:  

Mesh:

Year:  2007        PMID: 17597793     DOI: 10.1038/sj.gt.3302979

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  23 in total

1.  Mechanism of reduction in titers from lentivirus vectors carrying large inserts in the 3'LTR.

Authors:  Fabrizia Urbinati; Paritha Arumugam; Tomoyasu Higashimoto; Anil Perumbeti; Kyle Mitts; Ping Xia; Punam Malik
Journal:  Mol Ther       Date:  2009-04-21       Impact factor: 11.454

Review 2.  The use of chromatin insulators to improve the expression and safety of integrating gene transfer vectors.

Authors:  David W Emery
Journal:  Hum Gene Ther       Date:  2011-03-25       Impact factor: 5.695

3.  Comparison of Lentiviral Packaging Mixes and Producer Cell Lines for RNAi Applications.

Authors:  Christian Albrecht; Stefanie Hosiner; Brigitte Tichy; Silke Aldrian; Stefan Hajdu; Sylvia Nürnberger
Journal:  Mol Biotechnol       Date:  2015-06       Impact factor: 2.695

Review 4.  Biosafety features of lentiviral vectors.

Authors:  Axel Schambach; Daniela Zychlinski; Birgitta Ehrnstroem; Christopher Baum
Journal:  Hum Gene Ther       Date:  2013-02       Impact factor: 5.695

Review 5.  Evolving lessons on nanomaterial-coated viral vectors for local and systemic gene therapy.

Authors:  Dayananda Kasala; A-Rum Yoon; Jinwoo Hong; Sung Wan Kim; Chae-Ok Yun
Journal:  Nanomedicine (Lond)       Date:  2016-06-27       Impact factor: 5.307

6.  Neonatal gene therapy of glycogen storage disease type Ia using a feline immunodeficiency virus-based vector.

Authors:  Albert Grinshpun; Reba Condiotti; Simon N Waddington; Michael Peer; Eli Zeig; Sima Peretz; Alina Simerzin; Janice Chou; Chi-Jiunn Pann; Hilla Giladi; Eithan Galun
Journal:  Mol Ther       Date:  2010-06-22       Impact factor: 11.454

Review 7.  The transformative potential of HSC gene therapy as a genetic medicine.

Authors:  Pervinder Sagoo; H Bobby Gaspar
Journal:  Gene Ther       Date:  2021-05-26       Impact factor: 5.250

8.  Lentiviral vectors to probe and manipulate the Wnt signaling pathway.

Authors:  Christophe Fuerer; Roel Nusse
Journal:  PLoS One       Date:  2010-02-23       Impact factor: 3.240

9.  Efficient lentiviral transduction of human mesenchymal stem cells that preserves proliferation and differentiation capabilities.

Authors:  Paul Lin; Yuan Lin; Donald P Lennon; Diego Correa; Mark Schluchter; Arnold I Caplan
Journal:  Stem Cells Transl Med       Date:  2012-11-29       Impact factor: 6.940

10.  Lentiviral vectors with amplified beta cell-specific gene expression.

Authors:  K L Shaw; E Pais; S Ge; C Hardee; D Skelton; R P Hollis; G M Crooks; D B Kohn
Journal:  Gene Ther       Date:  2009-05-14       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.